Precigen Reports Third Quarter 2022 Financial Results and Pr

– Company will host virtual R&D event in early January 2023, timed to coincide with the 41st Annual JP Morgan Healthcare Conference, to showcase complete...

Related Keywords

Minnesota , United States , Mayo Clinic In Rochester , American , Harry Thomasian Jr , Stevenm Harasym , Helen Sabzevari , Clintt Allen , National Cancer Institute , Surgical Oncology Program , Drug Administration , Nasdaq , Exchange Commission , Cancer Research , American Society Of Hematology , Key Program , Precigen Inc , Healthcare Conference , American Society , Annual Meeting , Trans Ova , Senior Investigator , Safety Study , Positive Acute Myeloid Leukemia , Higher Risk Myelodysplastic Syndromes , Mayo Clinic , Dose Level , Dose Expansion Study , Advanced Hematologic , Solid Tumor Malignancies , First Nine Months , Results Compared , Prior Year , Advancing Medicine , Annual Report , Precigen , Nc ,